We provide you with 20 years of free, institutional-grade data for ZVSA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ZVSA. Explore the full financial landscape of ZVSA stock.
| Reported Date | CIK | Ticker | Type |
|---|
ZyVersa Therapeutics, Inc.(NASDAQ:ZVSA) 
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and...
Website: https://www.zyversa.com
Founded: 2014
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about ZVSA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.